FIELD: medicine. SUBSTANCE: it is suggested to apply preparation to suppress C1q subcomponent and C1 component of human complement system as hypoxen (olifen) of the following structural formula:  , where n = 0-4. The innovation could be applied for treating diseases accompanied by pathological activation of classic way of human complement system. EFFECT: increased number of preparations of mentioned indication. 6 tbl
, where n = 0-4. The innovation could be applied for treating diseases accompanied by pathological activation of classic way of human complement system. EFFECT: increased number of preparations of mentioned indication. 6 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD OF DETERMINING FUNCTIONAL ACTIVITY OF HUMAN COMPLEMENT C1 INHIBITOR | 2001 | 
 | RU2195662C1 | 
| METHOD OF ASSAY OF SUBSTANCE EFFECT ON COMPLEMENT IN STAGE OF SUBCOMPONENT C IQ BINDING | 2001 | 
 | RU2190219C1 | 
| METHOD FOR DETERMINATION OF FUNCTIONAL ACTIVITY OF C1rs SUBCOMPONENTS OF THE FIRST HUMAN COMPLEMENT COMPONENT | 2003 | 
 | RU2235329C1 | 
| METHOD FOR ASSAY OF IMMUNE STATUS DISORDER | 2002 | 
 | RU2247381C2 | 
| METHOD OF ASSAY OF SUBSTANCE EFFECT ON COMPLEMENT (VARIANTS) | 1999 | 
 | RU2162602C1 | 
| METHOD FOR DETECTING FUNCTIONAL ACTIVITY OF SUBCOMPONENTS C1rs OF THE FIRST COMPONENT OF HUMAN COMPLEMENT | 2003 | 
 | RU2251698C1 | 
| METHOD OF ASSAY OF INHIBITORY EFFECT OF SUBSTANCES ON COMPLEMENT | 2000 | 
 | RU2195665C2 | 
| METHOD AND KIT FOR IMMUNE-ENZYME FUNCTIONAL ACTIVITY ASSAY ON C1rs SUBCOMPONENTS OF FIRST COMPONENT OF HUMAN COMPLEMENT | 2010 | 
 | RU2425383C1 | 
| METHOD OF ASSAY OF FUNCTIONAL ACTIVITY OF COMPONENT C2 IN HUMAN COMPLEMENT | 2001 | 
 | RU2195670C1 | 
| SCREENING TEST FOR DETERMINATION OF THE FUNCTIONAL ACTIVITY OF THE RAT COMPLEMENT SYSTEM | 2022 | 
 | RU2786208C1 | 
Authors
Dates
2003-05-27—Published
2002-07-11—Filed